Palatin Technologies (PTN) Capital Leases (2011 - 2023)
Palatin Technologies' (PTN) quarterly Capital Leases came in at $18527.0 in Q3 2023, down 85.33% YoY from $126333.0 in Q3 2022, and down 59.74% on a QoQ basis from $46014.0 in Q2 2023.
Palatin Technologies (PTN) Capital Leases (2011 - 2023) Analysis & Trends
Palatin Technologies (PTN) has 7 years of Capital Leases data on file, last reported at $18527.0 in Q3 2023.
- Quarterly Capital Leases fell 85.33% year-over-year to $18527.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $18527.0 (down 85.33% YoY) and the FY2023 annual result came in at $46014.0, down 69.81% from the prior year.
- Capital Leases declined to $18527.0 in Q3 2023, from $46014.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $178139.0 in Q1 2022 to a low of $18527.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 18,527.00 |
| Jun 30, 2023 | 46,014.00 |
| Mar 31, 2023 | 73,141.00 |
| Dec 31, 2022 | 99,912.00 |
| Sep 30, 2022 | 126,333.00 |
| Jun 30, 2022 | 152,407.00 |
| Mar 31, 2022 | 178,139.00 |
| Sep 30, 2016 | 7,214.00 |
| Jun 30, 2016 | 14,324.00 |
| Jun 30, 2015 | 41,749.00 |
| Mar 31, 2013 | 2,048.00 |
| Dec 31, 2012 | 8,116.00 |
| Sep 30, 2012 | 14,068.00 |
| Jun 30, 2012 | 19,909.00 |
| Mar 31, 2012 | 25,638.00 |
| Dec 31, 2011 | 31,260.00 |
| Sep 30, 2011 | 36,775.00 |
| Jun 30, 2011 | 42,186.00 |